Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mannon Geindreau
Observed names:
Geindreau, Mannon,
Mannon GEINDREAU
Institutions:
Inserm,
Université de Bourgogne,
Karolinska Institutet,
Centre de recherche Translationnelle en Médecine moléculaire
Observed institutions:
Inserm,
Université de Bourgogne,
Karolinska Institutet,
Université Bourgogne Franche-Comté,
Centre de recherche Translationnelle en Médecine moléculaire
ORCID:
0000-0003-0926-1998
Observed ORCID:
0000-0003-0926-1998
OpenAlex ID:
A5041237753
Natural Killer cells at the frontline in the fight against cancer
2024
·
Loïs Coënon
, Mannon Geindreau
, et al.
·
Cell Death and Disease
·
139
PDF
Role of Cytokines and Chemokines in Angiogenesis in a Tumor Context
2022
·
Mannon GEINDREAU
, Mélanie BRUCHARD
, et al.
·
Cancers
·
131
PDF
Vascular Endothelial Growth Factor, a Key Modulator of the Anti-Tumor Immune Response
2021
·
Mannon Geindreau
, François Ghiringhelli
, et al.
·
International Journal of Molecular Sciences
·
119
PDF
Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses
2022
·
Mélanie Bruchard
, Mannon Geindreau
, et al.
·
Nature Immunology
·
99
The intrinsic expression of NLRP3 in Th17 cells promotes their protumor activity and conversion into Tregs
2025
·
Théo Accogli
, Christophe Hibos
, et al.
·
Cellular and Molecular Immunology
·
29
PDF
IL-10 secretion by CD8 T cells orchestrates early NK cell recruitment and antitumor immunity after anti-VEGFR-2/PD-1 therapy
2026
·
Mannon Geindreau
, Cassandre Pignol
, et al.
·
Journal for ImmunoTherapy of Cancer
·
1
CD8⁺ T Cell infiltration and spatial organization in cancer: mechanisms, barriers, and therapeutic strategies
2026
·
Lylou Milian
, Mannon Geindreau
, et al.
·
Molecular Biomedicine
PDF
Neutral sphingomyelinases restrict natural killer cells activity against lung cancer
2026
·
Riccardo Cinotti
, Mannon Geindreau
, et al.
·
Cancer Immunology Immunotherapy
PDF
Study of the immune system following the therapeutic combination of an immune checkpoint inhibitor and an anti-angiogenic agent in cancer
2024
·
Geindreau, Mannon
·
theses.fr (ABES)
Etude du système immunitaire suite à la combinaison thérapeutique d'un inhibiteur de point de contrôle immunitaire et d'un anti-angiogénique dans le cancer
2024
·
Mannon Geindreau
Show more works
View as search
Works count:
10
Citation count:
516
H-index:
5
I10-index:
5
Year
Topic
Type